Chongqing Genrix Biopharmaceutical (SH:688443) Xin Lang Cai Jing·2025-10-31 02:54Group 1 - The core viewpoint of the news is the disclosure of institutional holdings in Zhixiang Jintai (688443.SH) as of October 30, 2025, indicating significant institutional interest with 16 investors holding a total of 253 million shares, representing 68.87% of the total share capital [1] - The top ten institutional investors collectively hold 67.11% of the shares, with a decrease of 1.29 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, three funds reported a decrease in holdings compared to the previous quarter, with a total reduction of 0.99% [2] - Two new public funds were disclosed during this period, including the Fuguo Optimized Enhanced Bond A/B and the Huaxia CSI Biotech Theme ETF Initiated A [2] - A total of 165 public funds were not disclosed in this period, including notable funds such as the Industrial Bank Medical Health Stock A and the Southern CSI 1000 ETF [2] - One social security fund, the National Social Security Fund 413 Portfolio, was not disclosed in this period [2]